| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/23/2005 | CN1599607A Carbinols for the treatment of neuropathic dysfunction |
| 03/23/2005 | CN1599606A Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins |
| 03/23/2005 | CN1599605A Pharmaceutical compositions and methods for administering EP2 receptor selective agonists |
| 03/23/2005 | CN1599604A Use of 4-oxobutanoic acid derivatives in the treatment of inflammation |
| 03/23/2005 | CN1599598A Controlled release polymeric compositions of bone growth promoting compounds |
| 03/23/2005 | CN1597912A Preparation process of traditional Chinese medicine bone wine |
| 03/23/2005 | CN1597689A Ledebouriella root glycoside and its preparation and application |
| 03/23/2005 | CN1597677A Compounds and methods for modulation of estrogen receptors |
| 03/23/2005 | CN1597667A Quinazoline derivatives as angiogenesis inhibitors |
| 03/23/2005 | CN1596979A Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 03/23/2005 | CN1596947A Bone Activating stasis transforming capsule |
| 03/23/2005 | CN1596945A Chinese herbal plant medicinal oil |
| 03/23/2005 | CN1596931A Chinese medicinal composition for treating rheumatism rheumatoid disease and protrasion of lumbar intervertebral disk and its preparation method |
| 03/23/2005 | CN1596930A Muscle and bone pain plaster and its making method |
| 03/23/2005 | CN1596929A Plaster for treating acute and chronic muscle and bone disease and its preparation method |
| 03/23/2005 | CN1596920A Medicinal composition for treating cardiopathy and its preparation method and use |
| 03/23/2005 | CN1596901A Ledebouriella root extract preparation used for treating climacteric syndrome and preparation method |
| 03/23/2005 | CN1596899A Dexamehasone palmitate freeze-dried emulsion and its preparation method |
| 03/23/2005 | CN1596895A Kusnezoff monkshood root methyl element microcapsule and its production method |
| 03/23/2005 | CN1193785C Medicine for treating rheumatic and rheumatoid diseases |
| 03/23/2005 | CN1193782C medicine for treating cervical vertebrae, lumbar vertebrae pain |
| 03/23/2005 | CN1193775C Medicine for treating atrophic arthritis, ankylosing sponylitis |
| 03/23/2005 | CN1193772C Capsule for dredging channels and removing blood stasis and its making method |
| 03/23/2005 | CN1193764C Novel medicinal use and prepn process of steroid general saponin of Rhizomz Anemarrhenae as Chinese medicine |
| 03/23/2005 | CN1193761C Controllable release system of glucocorticoid and its preparation method |
| 03/23/2005 | CN1193751C Therpauetic agent of osteoporisis comprising active ingredient of quercetin derivatives |
| 03/23/2005 | CN1193746C Substituted nitrobenzene derimative for medicine and other use |
| 03/23/2005 | CN1193745C Salmon calcitonin snuff inhalant and its prepn method |
| 03/22/2005 | US6870044 Regulatory sequences for use as tool in controlling heterologous gene expression in cells |
| 03/22/2005 | US6869975 Linked biaryl compounds |
| 03/22/2005 | US6869969 Isoxazole estrogen receptor agonist and antagonist |
| 03/22/2005 | US6869956 Such as 4-(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a) quinoxaline; kits; treating arthritis, psoriasis, inflammatory bowel disease, autoimmune diseases and neurodegenerative diseases among others |
| 03/22/2005 | US6869954 Water-soluble phenylpyridazine compounds and compositions containing the same |
| 03/22/2005 | US6869952 Such as 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo(2,1-f)(1,2,4)triazin-6-ol; for treament of cancer |
| 03/22/2005 | US6869951 Such as N-(2-(4-morphoolinyl)ethyl)-N-((4-((4-pentyl-benzoyl)amino)phenyl)sulfonyl) -D-valine; for treatment of osteoarthritis |
| 03/22/2005 | US6869945 Antihistamines; respiratory system disorders; antiinflammatory agents |
| 03/22/2005 | US6869941 Combination of drospirenone and an estrogen sulphamate for HRT |
| 03/22/2005 | US6869926 Comprises amylin/adrenomedullin which stimulates chondrocyte proliferation; for treatment of cartilage disorders/bone growth disorders |
| 03/22/2005 | US6869615 Enterically coated to prevent gastrointestinal side effects |
| 03/17/2005 | WO2005023288A1 Treatment of fibrotic disease |
| 03/17/2005 | WO2005023281A1 Composition comprising notoginseng radix extract for preventing and treating arthritis as an effective ingredient |
| 03/17/2005 | WO2005023263A1 Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis |
| 03/17/2005 | WO2005014026A3 Use of cxcl6 chemokine in the prevention or repair of cartilage defects |
| 03/17/2005 | WO2005009431B1 Methods for treating inflammation and inflammation-associated diseases with a statin and ether |
| 03/17/2005 | WO2004082608A9 Ligands for tgf-beta binding proteins and uses thereof |
| 03/17/2005 | WO2004056868A3 Nf-hev compositions and methods of use |
| 03/17/2005 | WO2004056809A8 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 03/17/2005 | WO2004056808A8 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 03/17/2005 | WO2002050028A8 Substituted benzoindoles as spla2 inhibitors |
| 03/17/2005 | US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor |
| 03/17/2005 | US20050059700 Reacting compunds such as 6-methyl-12-oxa-tricyclo[8.2.1.0]trideca-2,4,6-trien-11-ol with compounds such as 4-(2,6-dichloro-phenyl)-piperidine to produce (+-)-cis-1-methyl-7-[[4-(2,6-dichloro-phenyl)piperidin-1-yl)]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol |
| 03/17/2005 | US20050059699 N-acylated lipophilic amino acid derivatives |
| 03/17/2005 | US20050059688 administering nontoxic, preferential and potent c-kit ligand inhibitors such as imatinib, to humans for treatment of inflammatory diseases such as rheumatoid arthritis |
| 03/17/2005 | US20050059686 Pyrrolopyrimidines as phosphodiesterase vII inhibitors |
| 03/17/2005 | US20050059685 such as R)-1,5-Dimethyl 3-(5-hydroxyhexyl)pyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione, used for the treatment or prevention of symptoms or manifestations associated with diseases or disorders affected by cytokine intracellular signaling |
| 03/17/2005 | US20050059666 CCR5 antagonists useful for treating AIDS |
| 03/17/2005 | US20050059665 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 03/17/2005 | US20050059657 Aminoisoxazole derivatives active as kinase inhibitors |
| 03/17/2005 | US20050059625 Immunostimulatory nucleic acid molecules |
| 03/17/2005 | US20050059618 Men protein, gst2, rab-rp1, csp, f-box protein lilina/fbl7, abc50, coronin, sec61 alpha, or vhappa1-1, or homologous proteins involved in the regulation of energy homeostasis |
| 03/17/2005 | US20050059616 administering flavonoids and optionally vitamin E or excipients for the prophylaxis of bone or cardiovascular disorders, headaches, hypertension, cancers, leukemia, arteriosclerosis, Alzheimer's disease, inflammatory diseases, rheumatic diseases, acne, alopecia or psoriasis |
| 03/17/2005 | US20050059577 Glycosylphosphatidylinositol containing polypeptides |
| 03/17/2005 | US20050059093 Method for detecting modulators of Notch signalling |
| 03/17/2005 | US20050058639 Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| 03/17/2005 | CA2537281A1 Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis |
| 03/17/2005 | CA2535021A1 Use of insp035 to treat fibrotic disease |
| 03/16/2005 | EP1514867A2 Substituted phenyl derivatives, their preparation and use |
| 03/16/2005 | EP1514557A1 Preventives/remedies for bone and joint diseases |
| 03/16/2005 | EP1514552A1 Novel fused imidazole derivative |
| 03/16/2005 | EP1514540A1 Calcium-containing tissue strengthening agents and use thereof |
| 03/16/2005 | EP1514539A2 Micro-encapsulated topical analgesic for pain relief and sleeve comprising it |
| 03/16/2005 | EP1513942A2 Galactosyl isomalt, method for production and use thereof |
| 03/16/2005 | EP1513880A1 Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation |
| 03/16/2005 | EP1513864A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 03/16/2005 | EP1513842A1 Substituted hexahydropyrrolo (1,2-a)pyrazines, octahydropyrido(1,2-a)pyrazines and decahydropyrazino(1,2-a)azepines |
| 03/16/2005 | EP1513837A1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 03/16/2005 | EP1513836A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 03/16/2005 | EP1513835A1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 03/16/2005 | EP1513830A1 Bisindolyl-maleimid derivatives as kinase inhibitors |
| 03/16/2005 | EP1513827A1 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors |
| 03/16/2005 | EP1513821A1 Protein kinase inhibitors |
| 03/16/2005 | EP1513820A2 Compounds, compositions, and methods |
| 03/16/2005 | EP1513810A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans |
| 03/16/2005 | EP1513808A2 Fluorinated cyclic amides as dipeptidyl peptidase iv inhibitors |
| 03/16/2005 | EP1513793A1 Novel ligands that are inhibitors of the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 03/16/2005 | EP1513589A1 1,5-disubstituted pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma |
| 03/16/2005 | EP1513588A2 Use of new etonogestrel esters |
| 03/16/2005 | EP1513560A2 Method of magnetically manipulating a cell with magnetisable particles |
| 03/16/2005 | EP1513543A2 Fas peptide mimetics and uses thereof |
| 03/16/2005 | EP1513531A1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 03/16/2005 | EP1513529A1 Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 03/16/2005 | EP1513523A1 1,5-disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases |
| 03/16/2005 | EP1513516A1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS ANDPROCESSES FOR PREPARING AND THEIR USES |
| 03/16/2005 | EP1513494A2 Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
| 03/16/2005 | EP1345612B1 Use of low molecular heparin for treating osteoarthritis |
| 03/16/2005 | EP1250358B1 Therapeutic peptides |
| 03/16/2005 | EP1233959B1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 03/16/2005 | EP1171143B9 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same |
| 03/16/2005 | EP1117296B1 Combination of bisphosphonate and tetracycline |
| 03/16/2005 | EP0907737B1 Il-6 mutein |